The first vaccine against dengue fever won clearance in Mexico, an initial step toward preventing the mosquito-borne infection that puts half of the world's population at risk. Sanofi expects more approvals in 'upcoming weeks' for the product, called Dengvaxia, in Latin America and Asia, Olivier Charmeil, who heads the Paris-based company's vaccines unit, said.
Read More...